An Open-Label Trial of Memantine for Cognitive Impairment in Patients with Posttraumatic Stress Disorder

Table 1

Demographic and baseline characteristics.

	(%)
Ethnicity
African American	3
White	23 (76)
Hispanic	0
Asian	0
Other	0
Gender
Male	24 (92)
Female	2 (8)
Age (mean/SD)	56.88 years (3.9)